Clothing & Shoes

Dr Martens downgrades FY guidance amid higher costs

According to the retailer, it maintains FY24 revenue growth guidance of mid to high single digits on a constant currency basis

Dr Martens has downgraded the group’s FY23 guidance with EBITDA now expected to be around £245m due to higher costs at its US stores and lower wholesale revenue. 

Back to top button